{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T12:01:21Z","timestamp":1791028881770,"version":"4.1.0"},"reference-count":46,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2008,4,1]],"date-time":"2008-04-01T00:00:00Z","timestamp":1207008000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,4,1]],"date-time":"2008-04-01T00:00:00Z","timestamp":1207008000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["molpharm.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Pharmacology"],"published-print":{"date-parts":[[2008,4]]},"DOI":"10.1124\/mol.107.043190","type":"journal-article","created":{"date-parts":[[2008,1,9]],"date-time":"2008-01-09T03:44:02Z","timestamp":1199850242000},"page":"1274-1281","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Role of Lysine 411 in Substrate Carboxyl Group Binding to the Human Reduced Folate Carrier, as Determined by Site-Directed Mutagenesis and Affinity Inhibition"],"prefix":"10.1016","volume":"73","author":[{"given":"Yijun","family":"Deng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhanjun","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Cherian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianmei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleem","family":"Gangjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larry H.","family":"Matherly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/mol.107.043190_REF1","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s002280050404","article-title":"Pharmacokinetics of low doses of methotrexate in patients with psoriasis over the early period of treatment","volume":"53","author":"Chl\u00e1dek","year":"1998","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1124\/mol.107.043190_REF2","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0021-9258(17)42301-5","article-title":"A novel cDNA restores reduced folate carrier activity and methotrexate sensitivity to transport deficient cells","volume":"269","author":"Dixon","year":"1994","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.107.043190_REF3","doi-asserted-by":"crossref","first-page":"30855","DOI":"10.1074\/jbc.M003988200","article-title":"Clustering of mutations in the first transmembrane domain of the human reduced folate carrier in GW1843U89-resistant leukemia cells with impaired antifolate transport and augmented folate uptake","volume":"275","author":"Drori","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.107.043190_REF4","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1016\/S0021-9258(19)68121-4","article-title":"Rapid formation of poly-\u03b3-glutamyl derivatives of methotrexate and their association with dihydrofolate reductase as assessed by high pressure liquid chromatography in the Ehrlich ascites tumor cells in vitro","volume":"257","author":"Fry","year":"1982","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.107.043190_REF5","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1021\/jm010575m","article-title":"Synthesis of N-[4-[1-ethyl-2-(2,4-diaminofuro[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]-l-glutamic acid as an antifolate","volume":"45","author":"Gangjee","year":"2002","journal-title":"J Med Chem"},{"key":"10.1124\/mol.107.043190_REF6","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1158\/1078-0432.CCR-06-2145","article-title":"Prognostic role of the reduced folate carrier, the major membrane transporter for methotrexate, in childhood acute lymphoblastic leukemia: a report from the Children\u2019s Oncology Group","volume":"13","author":"Ge","year":"2007","journal-title":"Clin Cancer Res"},{"key":"10.1124\/mol.107.043190_REF7","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1056\/NEJM199204163261602","article-title":"Methotrexate in resistant juvenile rheumatoid arthritis. Results of the U.S.A.-U.S.S.R. double-blind, placebo-controlled trial. The Pediatric Rheumatology Collaborative Study Group and The Cooperative Children\u2019s Study Group","volume":"326","author":"Giannini","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1124\/mol.107.043190_REF8","doi-asserted-by":"crossref","first-page":"5007","DOI":"10.1016\/S0021-9258(18)91984-8","article-title":"Carrier-mediated transport of the folic acid analogue methotrexate, in the L1210 leukemia cell","volume":"243","author":"Goldman","year":"1968","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.107.043190_REF9","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1053\/sonc.2002.37461","article-title":"Molecular, biochemical, and cellular pharmacology of pemetrexed","volume":"29","author":"Goldman","year":"2002","journal-title":"Semin Oncol"},{"key":"10.1124\/mol.107.043190_REF10","doi-asserted-by":"crossref","first-page":"2494","DOI":"10.1182\/blood.V89.7.2494","article-title":"Molecular mechanism of antifolate transport-deficiency in a methotrexate-resistant MOLT-3 human leukemia cell line","volume":"89","author":"Gong","year":"1997","journal-title":"Blood"},{"key":"10.1124\/mol.107.043190_REF11","first-page":"621","article-title":"Mechanisms of methotrexate resistance in osteosarcoma","volume":"5","author":"Guo","year":"1999","journal-title":"Clin Cancer Res"},{"key":"10.1124\/mol.107.043190_REF12","doi-asserted-by":"crossref","first-page":"4558","DOI":"10.1016\/S0021-9258(17)43082-1","article-title":"Affinity labeling of the 5-methyltetrahydrofolate\/methotrexate transport protein of L1210 cells by treatment with an N-hydroxysuccinimide ester of [3H]methotrexate","volume":"259","author":"Henderson","year":"1984","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.107.043190_REF13","doi-asserted-by":"crossref","first-page":"36206","DOI":"10.1074\/jbc.M507295200","article-title":"Localization of a substrate binding domain of the human reduced folate carrier to transmembrane domain 11 by radioaffinity labeling and cysteine-substituted accessibility methods","volume":"280","author":"Hou","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.107.043190_REF14","doi-asserted-by":"crossref","first-page":"33588","DOI":"10.1074\/jbc.M607049200","article-title":"Transmembrane domains 4, 5, 7, 8, and 10 of the human reduced folate carrier are important structural or functional components of the transmembrane channel for folate substrates","volume":"281","author":"Hou","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.107.043190_REF15","series-title":"Anticancer Development Guide: Antifolate Drugs in Cancer Therapy","first-page":"293","article-title":"Receptor- and carrier-mediated transport systems for folates and antifolates: exploitation for folate chemotherapy and immunotherapy","author":"Jansen","year":"1999"},{"key":"10.1124\/mol.107.043190_REF16","doi-asserted-by":"crossref","first-page":"30189","DOI":"10.1074\/jbc.273.46.30189","article-title":"A structurally altered human reduced folate carrier with increased folic acid transport mediates a novel mechanism of antifolate resistance","volume":"273","author":"Jansen","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.107.043190_REF17","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1038\/227680a0","article-title":"Cleavage of structural proteins during the assembly of the head of bacteriophage T4","volume":"227","author":"Laemmli","year":"1970","journal-title":"Nature"},{"key":"10.1124\/mol.107.043190_REF18","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","article-title":"Protein measurement with the Folin phenol reagent","volume":"193","author":"Lowry","year":"1951","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.107.043190_REF19","first-page":"3420","article-title":"Identification of a highly glycosylated methotrexate membrane carrier in K562 erythroleukemia cells up-regulated for tetrahydrofolate cofactor and methotrexate transport","volume":"51","author":"Matherly","year":"1991","journal-title":"Cancer Res"},{"key":"10.1124\/mol.107.043190_REF20","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S0083-6729(03)01012-4","article-title":"Membrane transport of folates","volume":"66","author":"Matherly","year":"2003","journal-title":"Vitam Horm"},{"key":"10.1124\/mol.107.043190_REF21","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s10555-007-9046-2","article-title":"Human reduced folate carrier: translation of basic biology to cancer etiology and therapy","volume":"26","author":"Matherly","year":"2007","journal-title":"Cancer Metastasis Rev"},{"key":"10.1124\/mol.107.043190_REF22","doi-asserted-by":"crossref","first-page":"10035","DOI":"10.1016\/S0021-9258(18)61070-1","article-title":"Sequence from picomole quantities of proteins electroblotted onto polyvinylidene difluoride membranes","volume":"262","author":"Matsudaira","year":"1989","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.107.043190_REF23","first-page":"3790","article-title":"Isolation of a gene encoding a human reduced folate carrier (RFC1) and analysis of its expression in transport-deficient, methotrexate-resistant human breast cancer cells","volume":"55","author":"Moscow","year":"1995","journal-title":"Cancer Res"},{"key":"10.1124\/mol.107.043190_REF24","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.bbaexp.2006.12.006","article-title":"Effects of 5\u2032untranslated region diversity on the posttranscriptional regulation of the human reduced folate carrier","volume":"1769","author":"Payton","year":"2007","journal-title":"Biochim Biophys Acta"},{"key":"10.1124\/mol.107.043190_REF25","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1006\/bbrc.1995.1096","article-title":"Molecular cloning of the human placental folate transporter","volume":"206","author":"Prasad","year":"1995","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1124\/mol.107.043190_REF26","doi-asserted-by":"crossref","first-page":"2526","DOI":"10.1074\/jbc.273.5.2526","volume":"273","author":"Roy","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.107.043190_REF27","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1042\/bj3460509","article-title":"Mutations in the reduced-folate carrier affect protein localization and stability","volume":"346","author":"Sadlish","year":"2000","journal-title":"Biochem J"},{"key":"10.1124\/mol.107.043190_REF28","doi-asserted-by":"crossref","first-page":"42105","DOI":"10.1074\/jbc.M206459200","article-title":"Functional role of arginine 373 in substrate translocation by the reduced folate carrier","volume":"277","author":"Sadlish","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.107.043190_REF29","doi-asserted-by":"crossref","first-page":"9840","DOI":"10.1016\/S0021-9258(19)81593-4","article-title":"Evidence for a functional defect in the translocation of the methotrexate transport carrier in a methotrexate-resistant murine L1210 leukemia cell line","volume":"263","author":"Schuetz","year":"1988","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.107.043190_REF30","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/S0026-895X(24)12559-X","article-title":"Mutational analysis of the functional role of conserved arginine and lysine residues in transmembrane domains of the murine reduced folate carrier","volume":"59","author":"Sharina","year":"2001","journal-title":"Mol Pharmacol"},{"key":"10.1124\/mol.107.043190_REF31","first-page":"4442","article-title":"Relative frequency and kinetic properties of transport-defective phenotypes among methotrexate resistant L1210 clonal cell lines derived in vivo","volume":"41","author":"Sirotnak","year":"1981","journal-title":"Cancer Res"},{"key":"10.1124\/mol.107.043190_REF32","series-title":"Folic Acid Metabolism in Health and Disease","first-page":"1","article-title":"Historical perspective on key advances in the biochemistry and physiology of folates","author":"Stokstad","year":"1990"},{"key":"10.1124\/mol.107.043190_REF33","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S0026-895X(25)10494-X","article-title":"Carrier- and receptor-mediated transport of folate antagonists targeting folate-dependent enzymes correlates of molecular-structure and biological activity","volume":"48","author":"Westerhof","year":"1995","journal-title":"Mol Pharmacol"},{"key":"10.1124\/mol.107.043190_REF34","doi-asserted-by":"crossref","first-page":"2987","DOI":"10.1074\/jbc.270.7.2987","article-title":"Isolation of a human cDNA that complements a mutant hamster cell defective in methotrexate uptake","volume":"270","author":"Williams","year":"1995","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.107.043190_REF35","doi-asserted-by":"crossref","first-page":"5810","DOI":"10.1016\/S0021-9258(17)37534-8","article-title":"Isolation of a hamster cDNA clone coding for a function involved in methotrexate uptake","volume":"269","author":"Williams","year":"1994","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.107.043190_REF36","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S0005-2736(02)00583-7","article-title":"Identification of lysine-411 in the human reduced folate carrier as an important determinant of substrate selectivity and carrier function by systematic site-directed mutagenesis","volume":"1567","author":"Witt","year":"2002","journal-title":"Biochim Biophys Acta"},{"key":"10.1124\/mol.107.043190_REF37","doi-asserted-by":"crossref","first-page":"46755","DOI":"10.1074\/jbc.M408696200","article-title":"Restoration of transport activity by co-expression of human reduced folate carrier half molecules in transport impaired K562 cells: localization of a substrate binding domain to transmembrane domains 7-12","volume":"279","author":"Witt","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.107.043190_REF38","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0006-2952(96)00710-1","article-title":"Human K562 transfectants expressing high levels of reduced folate carrier but exhibiting low transport activity","volume":"53","author":"Wong","year":"1997","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/mol.107.043190_REF39","doi-asserted-by":"crossref","first-page":"17468","DOI":"10.1074\/jbc.270.29.17468","article-title":"Isolation of human cDNAs that restore methotrexate sensitivity and reduced folate carrier activity in methotrexate transport-defective Chinese hamster ovary cells","volume":"270","author":"Wong","year":"1995","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.107.043190_REF40","doi-asserted-by":"crossref","first-page":"10388","DOI":"10.1074\/jbc.274.15.10388","article-title":"Impaired membrane transport in methotrexate-resistant CCRF-CEM cells involves early translation termination and increased turnover of a mutant reduced folate carrier","volume":"274","author":"Wong","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.107.043190_REF41","doi-asserted-by":"crossref","first-page":"6628","DOI":"10.1016\/S0021-9258(19)50473-2","article-title":"Alteration of folate analogue transport inward after induced maturation of HL-60 leukemia cells: molecular properties of the transporter in an overproducing variant and evidence for down-regulation of its synthesis in maturating cells","volume":"267","author":"Yang","year":"1992","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.107.043190_REF42","doi-asserted-by":"crossref","first-page":"7873","DOI":"10.1074\/jbc.273.14.7873","article-title":"A reduced carrier mutation produces substrate-dependent alterations in carrier mobility in murine leukemia cells and methotrexate resistance with conservation of growth in 5-formyltetrahydrofolate","volume":"273","author":"Zhao","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.107.043190_REF43","doi-asserted-by":"crossref","first-page":"19065","DOI":"10.1074\/jbc.273.30.19065","article-title":"A mutated murine reduced folate carrier (RFC1) with increased affinity for folic acid, decreased affinity for methotrexate, and an obligatory anion requirement for transport function","volume":"273","author":"Zhao","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.107.043190_REF44","doi-asserted-by":"crossref","first-page":"8735","DOI":"10.1158\/1078-0432.CCR-04-0932","article-title":"Antifolate resistance in a HeLa cell line associated with impaired transport independent of the reduced folate carrier","volume":"10","author":"Zhao","year":"2004","journal-title":"Clin Cancer Res"},{"key":"10.1124\/mol.107.043190_REF45","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1016\/S0006-2952(99)00257-9","article-title":"Discrimination among reduced folates and methotrexate as transport substrates by a phenylalanine substitution for serine within the predicted eighth transmembrane domain of the reduced folate carrier","volume":"58","author":"Zhao","year":"1999","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/mol.107.043190_REF46","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s10555-007-9047-1","article-title":"The molecular identity and characterization of a proton-coupled folate transporter-PCFT: biological ramifications and impact on the activity of pemetrexed","volume":"26","author":"Zhao","year":"2007","journal-title":"Cancer Metastasis Rev"}],"container-title":["Molecular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X24048259?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X24048259?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/mol.107.043190","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T23:41:03Z","timestamp":1739490063000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026895X24048259"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,4]]},"references-count":46,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2008,4]]}},"alternative-id":["S0026895X24048259"],"URL":"https:\/\/doi.org\/10.1124\/mol.107.043190","relation":{},"ISSN":["0026-895X"],"issn-type":[{"value":"0026-895X","type":"print"}],"subject":[],"published":{"date-parts":[[2008,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Role of Lysine 411 in Substrate Carboxyl Group Binding to the Human Reduced Folate Carrier, as Determined by Site-Directed Mutagenesis and Affinity Inhibition","name":"articletitle","label":"Article Title"},{"value":"Molecular Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/mol.107.043190","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 American Society for Pharmacology and Experimental Therapeutics. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}